Comparison of DOTA and NODAGA as chelates for 68Ga-labelled CDP1 as novel infection PET imaging agents by Mdlophane, A. H., Ebenhan, T., Marjanovic-Painter, B., Govender, T., Sathekge, M. M., Zeevaart, J. R.

Get full text

Comparison of DOTA and NODAGA as chelates for .sup.68Ga-labelled CDP1 as novel infection PET imaging agents by Mdlophane, A. H, Ebenhan, T, Marjanovic-Painter, B, Govender, T, Sathekge, M. M, Zeevaart, J. R

Get full text

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study by Sathekge, Mike M, Lawal, Ismaheel O, Bal, Chandrasekhar, Bruchertseifer, Frank, Ballal, Sajana, Cardaci, Giuseppe, Davis, Cindy, Eiber, Mathias, Hekimsoy, Türkay, Knoesen, Otto, Kratochwil, Clemens, Lenzo, Nat P, Mahapane, Johncy, Maserumule, Letjie C, Mdlophane, Amanda H, Mokoala, Kgomotso M G, Ndlovu, Honest, Pant, Vineet, Rathke, Hendrik, Reed, Janet, Sen, Ishita B, Singh, Aviral, Sood, Ashwani, Tauber, Robert, Thakral, Parul, Yadav, Madhav Prasad, Morgenstern, Alfred

Get full text

10 Oral: AKY-1189, a novel, first-in-class miniprotein radiopharmaceutical designed to deliver Actinium-225 (225Ac) to Nectin-4 expressing tumors with broad therapeutic application... by Sathekge, M., Ndlovu, H., Kabunda, J., Mdlophane, A., Ramonaheng, K., Mdanda, S., Shungube, M., Mzizi, Y., Qebetu, M., Sebatana, R., Mokoala, K., Mashigoane, K., Zane, K., More, S., Vorster, M., Nasr, K., Morley, T., Kovacs, J., Horton, J., Herrmann, K.

Get full text